Loading...
Viva Biotech Holdings
VBIZF•PNK
Healthcare
Biotechnology
$0.19
$0.00(0.00%)
Viva Biotech Holdings (VBIZF) Financial Performance & Income Statement Overview
Review Viva Biotech Holdings’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-7.84%
↓ 7.84%
Operating Income Growth
19.20%
↑ 19.20%
Net Income Growth
244.08%
↑ 244.08%
Operating Cash Flow Growth
-2.46%
↓ 2.46%
Operating Margin
9.46%
↑ 9.46%
Gross Margin
33.66%
↑ 33.66%
Net Profit Margin
-0.02%
↓ 0.02%
ROE
-0.01%
↓ 0.008%
ROIC
3.19%
↑ 3.19%
Viva Biotech Holdings (VBIZF) Income Statement & Financial Overview
Review Viva Biotech Holdings's (VBIZF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.005B | $981.82M | $1.01B | $1.14B |
| Cost of Revenue | $656.57M | $642.68M | $680.93M | $736.22M |
| Gross Profit | $348.25M | $339.14M | $332.46M | $405.97M |
| Gross Profit Ratio | $0.35 | $0.35 | $0.33 | $0.36 |
| R&D Expenses | $45.16M | $42.83M | $51.27M | $76.70M |
| SG&A Expenses | $194.98M | $174.77M | $213.95M | $203.84M |
| Operating Expenses | $240.14M | $217.59M | $265.21M | $294.58M |
| Total Costs & Expenses | $896.71M | $860.27M | $946.14M | $1.03B |
| Interest Income | $0.00 | $0.00 | $74.57M | $74.64M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $99.73M | $98.60M | $95.07M | $103.25M |
| EBITDA | $212.54M | $215.46M | $162.88M | $228.13M |
| EBITDA Ratio | $0.21 | $0.22 | $0.16 | $0.20 |
| Operating Income | $108.12M | $121.55M | $67.25M | $124.88M |
| Operating Income Ratio | $0.11 | $0.12 | $0.07 | $0.11 |
| Other Income/Expenses (Net) | $2.07M | $63.96M | -$159.96M | -$88.68M |
| Income Before Tax | $110.19M | $185.52M | -$92.70M | $36.75M |
| Income Before Tax Ratio | $0.11 | $0.19 | -$0.09 | $0.03 |
| Income Tax Expense | $32.44M | $41.28M | $20.74M | $23.09M |
| Net Income | $50.49M | $116.81M | -$117.13M | $1.01M |
| Net Income Ratio | $0.05 | $0.12 | -$0.12 | $0.001 |
| EPS | $0.02 | $0.05 | -$0.05 | $0.001 |
| Diluted EPS | $0.02 | $0.05 | -$0.05 | $0.001 |
| Weighted Avg Shares Outstanding | $2.79B | $2.34B | $2.14B | $1.92B |
| Weighted Avg Shares Outstanding (Diluted) | $3.59B | $2.14B | $2.14B | $1.92B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan